Published in Vaccine Weekly, February 22nd, 2006
Study 1: A lentiviral vector in a Pluronic F127 gel facilitates delivery to cells of the central nervous system (CNS).
"Lentiviral vectors have been demonstrated as efficient tools for gene delivery to the CNS. We describe a novel approach for vector delivery using the thermoresponsive gel Pluronic F127 as a carrier," researchers in England report.
"An HIV-1 lentiviral vector expressing GFP was contained in various concentrations of gel (15, 30, and 40%) and applied to cultures of 293T cells. FACS analysis of cells transduced with 8 ng...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-02-22)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.